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Abstract 37 
Approximately one-third of global CO2 fixation occurs in a phase-separated algal organelle 38 
called the pyrenoid. Existing data suggest that the pyrenoid forms by the phase separation of the 39 
CO2-fixing enzyme Rubisco with a linker protein; however, the molecular interactions 40 
underlying this phase separation remain unknown. Here we present the structural basis of the 41 
interactions between Rubisco and its intrinsically disordered linker protein EPYC1 (Essential 42 
Pyrenoid Component 1) in the model alga Chlamydomonas reinhardtii. We find that EPYC1 43 
consists of five evenly-spaced Rubisco-binding regions that share sequence similarity. Single-44 
particle cryo-electron microscopy of one of these regions in complex with Rubisco indicates that 45 
each Rubisco holoenzyme has eight binding sites for EPYC1, one on each Rubisco small 46 
subunit. Interface mutations disrupt binding, phase separation, and pyrenoid formation. Cryo-47 
electron tomography supports a model where EPYC1 and Rubisco form a co-dependent 48 
multivalent network of specific low-affinity bonds, giving the matrix liquid-like properties. Our 49 
results advance the structural and functional understanding of the phase separation underlying 50 
the pyrenoid, an organelle that plays a fundamental role in the global carbon cycle. 51 
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Main Text 52 
The CO2-fixing enzyme Rubisco drives the global carbon cycle, mediating the 53 
assimilation of approximately 100 gigatons of carbon per year1. The gradual decrease of 54 
atmospheric CO2 over billions of years
2 has made Rubisco’s job increasingly difficult, to the 55 
point where CO2 assimilation limits the growth rate of many photosynthetic organisms
3. This 56 
selective pressure is thought to have led to the evolution of CO2 concentrating mechanisms, 57 
which feed concentrated CO2 to Rubisco to enhance growth
4. Of these mechanisms, the most 58 
poorly understood relies on the pyrenoid, a phase separated organelle5 found in the chloroplast of 59 
nearly all eukaryotic algae and some land plants (Fig. 1a, b)6,7. The pyrenoid enhances the 60 
activity of Rubisco by clustering it around modified thylakoid membranes that supply Rubisco 61 
with concentrated CO2
8,9. 62 
For decades, the mechanism for packaging the Rubisco holoenzyme into the pyrenoid 63 
remained unknown. Recent work showed that in the leading model alga Chlamydomonas 64 
reinhardtii (Chlamydomonas hereafter), the clustering of Rubisco into the pyrenoid matrix 65 
requires the Rubisco-binding protein EPYC110. EPYC1 and Rubisco are the most abundant 66 
components of the pyrenoid and bind to each other. Moreover, combining purified EPYC1 and 67 
Rubisco together produces phase-separated condensates11 that mix internally at a rate similar to 68 
that observed for the matrix in vivo5, suggesting that these two proteins are sufficient to form the 69 
structure of the pyrenoid matrix. The sequence repeats within EPYC1 and eight-fold symmetry 70 
of the Rubisco holoenzyme led us to hypothesize that EPYC1 and Rubisco each have multiple 71 
binding sites for the other, allowing the two proteins to form a co-dependent condensate (Fig. 72 
1c)10. 73 
Here, we determined the structural basis that underlies the EPYC1-Rubisco condensate. 74 
Using biophysical approaches, we found that EPYC1 has five evenly spaced Rubisco-binding 75 
regions that share sequence homology and can bind to Rubisco as short peptides. We obtained 76 
cryo-electron microscopy structures showing that each of EPYC1’s Rubisco-binding regions 77 
forms an α-helix that binds one of Rubisco’s eight small subunits via salt bridges and 78 
hydrophobic interactions. Mapping of these binding sites onto Rubisco holoenzymes within the 79 
native pyrenoid matrix indicates that the linker sequences between Rubisco-binding regions on 80 
EPYC1 are sufficiently long to connect together adjacent Rubisco holoenzymes. These 81 
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discoveries advance the understanding of the pyrenoid and provide a high-resolution structural 82 




We could not directly determine the structure of full-length EPYC1 bound to Rubisco because 87 
mixing the two proteins together produces phase-separated condensates11. We thus aimed to first 88 
identify Rubisco-binding regions on EPYC1, and subsequently to use a structural approach to 89 
determine how these regions bind to Rubisco. 90 
 91 
EPYC1 has five nearly identical Rubisco-binding regions 92 
The intrinsically disordered nature of purified EPYC111 led us to hypothesize that the 93 
Rubisco-binding regions of EPYC1 were short and could bind to Rubisco as peptides without a 94 
need for tertiary folds. Therefore, to identify EPYC1 regions that bind to Rubisco, we 95 
synthesized a peptide array consisting of 18 amino acid peptides tiling across the full length 96 
EPYC1 sequence (Fig. 1d), and probed this array with native Rubisco purified from 97 
Chlamydomonas cells (Fig. 1e, f). 98 
Our tiling array revealed five evenly-spaced Rubisco-binding regions on EPYC1, each 99 
consisting of a predicted α-helix and an upstream region (Fig. 1g, h and Supplementary Table 3). 100 
We confirmed the binding regions using surface plasmon resonance (SPR; Extended Data Fig. 101 
1b, c). Sequence alignment guided by the five binding regions revealed that mature EPYC1 102 
consists entirely of five sequence repeats (Fig. 1i), in contrast to the previously defined four 103 
repeats and two termini10 (Extended Data Fig. 1a). Our alignment indicates that the previously 104 
defined EPYC1 N- and C- termini, which at the time were not considered part of the repeats, 105 
actually share sequence homology with the central repeats.  106 
The presence of a Rubisco-binding region on each of the previously defined EPYC1 107 
repeats (Extended Data Fig. 1a) explains our yeast two-hybrid observations12 that a single 108 
EPYC1 repeat can interact with Rubisco, that knocking out the α-helix in an EPYC1 repeat 109 
disrupts this interaction, and that decreasing the number of EPYC1 repeats leads to a 110 
proportional decrease in EPYC1 interaction with Rubisco. It also explains our observations that 111 
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decreasing the number of EPYC1 repeats leads to a proportional decrease in the tendency of 112 
EPYC1 and Rubisco to phase separate together11. 113 
 114 
EPYC1 binds to Rubisco small subunits 115 
The sequence homology of the five Rubisco-binding regions suggests that each region binds to 116 
Rubisco in a similar manner. To identify the binding site of EPYC1 on Rubisco, we determined 117 
three structures by using single-particle cryo-electron microscopy. The first structure consists of 118 
Rubisco in complex with peptide EPYC149-72, representing the first Rubisco-binding region of 119 
EPYC1 (2.13 Å overall resolution; ~2.5 Å EPYC1 peptide local resolution; Fig. 2, Extended 120 
Data Fig. 2-5; Supplementary Table 1). The second structure consists of Rubisco in complex 121 
with a second peptide, EPYC1106-135, representing the second, third and fourth Rubisco-binding 122 
regions of EPYC1 (2.06 Å overall resolution, ~2.5 Å EPYC1 peptide local resolution, Extended 123 
Data Fig. 6). The affinities of these peptides to Rubisco were low by protein interaction 124 
standards (KD ~3 mM; Extended Data Fig. 1d, e); thus, millimolar concentrations of peptide 125 
were required to approach full occupancy of peptide bound to Rubisco. For reference purposes, 126 
we also obtained a third structure of Rubisco in the absence of EPYC1 peptide (2.68 Å; 127 
Extended Data Fig. 2 and 3), which was nearly identical to the previously published X-ray 128 
crystallography structure13, with minor differences likely due to the absence of the substrate 129 
analog 2-CABP in the active site of Rubisco in our sample14 (Extended Data Fig. 4). 130 
The structures of Rubisco in complex with EPYC149-72 and of Rubisco in complex with 131 
EPYC1106-135 were remarkably similar, indicating that these two peptides and the corresponding 132 
four regions of EPYC1 each bind to the same site on the Rubisco holoenzyme. The Rubisco 133 
holoenzyme consists of a core of eight catalytic large subunits in complex with eight small 134 
subunits, four of which cap each end of the holoenzyme (Fig. 2b-e). In each structure, an EPYC1 135 
peptide was clearly visible bound to each Rubisco small subunit, suggesting that each Rubisco 136 
holoenzyme can bind up to eight EPYC1s (Fig. 2b-e and Extended Data Fig. 6b, c). 137 
 138 
Salt bridges and a hydrophobic interface mediate binding 139 
Both the EPYC149-72 and EPYC1106-135 peptides formed an extended chain that sits on top of the 140 
Rubisco small subunit’s two α-helices (Fig. 3a, b, Extended Data Fig. 6d, e). This binding site 141 
explains our previous observations that mutations in the Rubisco small subunit α-helices 142 
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disrupted yeast two-hybrid interactions between EPYC1 and the Rubisco small subunit12 and 143 
prevented Rubisco’s assembly into a pyrenoid in vivo15. The C-terminal regions of the EPYC149-144 
72 and EPYC1106-135 peptides (NW[R/K]QELESLR[N/S]) are well-resolved; each forms an α-145 
helix that runs parallel to helix B of the Rubisco small subunit (Fig. 3a, b). The peptides’ N-146 
termini extend the trajectory of the helix and follow the surface of the Rubisco small subunit 147 
(Fig. 2b-e, 3a-b and Extended Data Fig. 5, Extended Data Fig. 6b, c). The side chains of the 148 
peptides’ N-termini could not be well resolved, suggesting that these regions are more 149 
conformationally flexible. 150 
Our atomic models based on the density maps suggest that binding is mediated by salt 151 
bridges and a hydrophobic interface. Three residue pairs of EPYC149-72 likely form salt bridges 152 
(Fig. 3c, d and g): EPYC1 residues R64 and R71 interact with E24 and D23, respectively, of 153 
Rubisco small subunit α-helix A, and EPYC1 residue E66 interacts with R91 of Rubisco small 154 
subunit α-helix B. Furthermore, a hydrophobic interface is formed by W63, L67 and L70 of 155 
EPYC1 and M87, L90 and V94 of Rubisco small subunit helix B (Fig. 3e-g). Similar interactions 156 
were observed for the corresponding residues in EPYC1106-135 (Extended Data Fig. 6f-j). 157 
 158 
Binding and phase separation require interface residues 159 
To determine the importance of individual EPYC1 residues for binding, we investigated the 160 
impact on Rubisco binding of every possible single amino acid substitution for EPYC1’s first 161 
Rubisco-binding region by using a peptide array (Fig. 4a and Supplementary Table 4) and SPR 162 
(Extended Data Fig. 7). Consistent with our structural model, the peptide array indicated that 163 
EPYC1 salt bridge-forming residues R64, R71 and E66 and the hydrophobic interface residues 164 
W63, L67 and L70 were all required for normal EPYC1 binding to Rubisco. The strong 165 
agreement of our mutational analysis suggests that our structural model correctly represents 166 
EPYC1’s Rubisco-binding interface. 167 
To determine the importance of EPYC1’s Rubisco-binding regions for pyrenoid matrix 168 
formation, we assayed the impact of mutations in these regions on formation of phase separated 169 
droplets by EPYC1 and Rubisco in vitro. The phase boundary was shifted by mutating R64 in 170 
the first Rubisco-binding region and the corresponding K or R in the other four Rubisco-binding 171 
regions of EPYC1 (Fig. 4b and Extended Data Fig. 8), suggesting that the Rubisco-binding 172 
regions mediate condensate formation. 173 
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 174 
Pyrenoid matrix formation requires interface residues 175 
We validated the importance of Rubisco residues for binding to EPYC1 by yeast two-hybrid 176 
assays (Fig. 5a and Extended Data Fig. 9). A Rubisco small subunit D23A mutation, which 177 
eliminates the charge of the aspartate residue, had a severe impact on Rubisco small subunit 178 
interaction with EPYC1, as expected from the contribution of that residue to a salt bridge with 179 
R71 and homologous residues of EPYC1’s Rubisco-binding regions. Likewise, E24A and R91A 180 
each showed a moderate defect, consistent with the contributions of those residues to salt bridges 181 
with R64 and E66 (and homologous residues) of EPYC1, respectively. Additionally, M87D and 182 
V94D, mutations which convert hydrophobic residues to bulky charged residues, each had a 183 
severe impact on interaction, as expected from the participation of those residues in the 184 
hydrophobic interface. Combinations of these mutations abolished the interactions completely 185 
(Extended Data Fig. 9). 186 
To evaluate the importance of the binding interface in vivo, we generated 187 
Chlamydomonas strains with point mutations in the binding interface. Rubisco small subunit 188 
mutations D23A/E24A or M87D/V94D caused a growth defect under conditions requiring a 189 
functional pyrenoid (Fig. 5b, Extended Data Fig. 10a-b). Furthermore, the mutants lacked a 190 
visible pyrenoid matrix (Fig. 5c, d and Extended Data Fig. 10c), indicating that those Rubisco 191 
small subunit residues are required for matrix formation in vivo. The Rubisco mutants retained 192 
pyrenoid tubules16, as previously observed in other matrix-deficient mutants10,17-19. 193 
Together, our data demonstrate that EPYC1’s Rubisco-binding regions bind to the 194 
Rubisco small subunit α-helices via salt-bridge interactions and a hydrophobic interface, 195 
enabling the condensation of Rubisco into the phase separated matrix. 196 
 197 
A structural model for pyrenoid matrix formation 198 
The presence of multiple Rubisco-binding regions along the EPYC1 sequence supports a model 199 
where consecutive Rubisco-binding regions on the same EPYC1 polypeptide can bind to 200 
different Rubisco holoenzymes and thus hold them together to form the pyrenoid matrix. If this 201 
model is correct, we would expect that the ~40 amino acid “linker” regions between consecutive 202 
Rubisco-binding regions on EPYC1 (Fig. 1g, i) would be sufficient to span the distance between 203 
EPYC1-binding sites on neighboring Rubisco holoenzymes in the pyrenoid matrix. To test this 204 
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aspect of the model, we combined our atomic structure of the EPYC1-Rubisco interaction with 205 
the precise positions and orientations of Rubisco holoenzymes within the pyrenoid matrix of 206 
native cells that we had previously obtained by in-situ cryo-electron tomography5 (Fig. 6a, b). 207 
We mapped the positions of EPYC1 binding sites onto Rubisco holoenzymes in the matrix and 208 
measured the distances between nearest neighbor EPYC1 binding sites on adjacent holoenzymes 209 
(Fig. 6c, binding sites on the same holoenzyme were excluded in this analysis). The observed 210 
distances ranged from ~2 nm to ~7 nm, with a median distance of ~4 nm (Fig. 6d and 211 
Supplementary Table 5). 212 
A “linker” region of 40 amino acids is unlikely to be stretched to its maximum possible 213 
length of 14 nm in vivo due to the high entropic cost of this configuration. To determine whether 214 
a linker region can span the observed distances between nearest neighbor binding sites on 215 
adjacent Rubisco holoenzymes, we used a simple physics model to calculate the energy required 216 
to stretch a 40 amino acid chain to any given distance (Fig. 6d; see Methods). The model 217 
indicates that stretching the chain to ~7 nm requires an energy of 3 kBT (where kB is the 218 
Boltzmann constant and T is the temperature), which could reasonably be derived from thermal 219 
fluctuations. Thus, our data suggest that the linker region between consecutive Rubisco-binding 220 
sites on the EPYC1 polypeptide can span the distance between adjacent Rubisco holoenzymes to 221 
hold the pyrenoid matrix together in vivo. It also appears likely that, in addition to bridging 222 
neighboring Rubisco holoenzymes, consecutive Rubisco-binding regions on a given EPYC1 can 223 
bind multiple sites on one Rubisco holoenzyme, as the distance between the nearest binding sites 224 




In this study, we have determined the structural basis for pyrenoid matrix formation for the first 229 
time in any species. We found that in the model alga Chlamydomonas, the intrinsically 230 
disordered protein EPYC1 has five regions of similar sequence that can bind to Rubisco as short 231 
peptides. These EPYC1 regions form an α-helix that binds to the Rubisco small subunit α-helices 232 
via salt bridges and hydrophobic interactions. EPYC1’s Rubisco-binding regions are spaced by 233 
linker sequences that are sufficiently long to span the distance between binding sites on adjacent 234 
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Rubisco holoenzymes within the pyrenoid, allowing EPYC1 to serve as a molecular glue that 235 
clusters Rubisco together to form the pyrenoid matrix (Fig. 6e). 236 
The multivalency of EPYC1 and the high KD (~3 mM; Extended Data Fig. 1e) of 237 
individual Rubisco-binding regions are consistent with the emerging principle that cellular phase 238 
separation is mediated by weak multivalent interactions20. The high dissociation rate constant 239 
(>1/s; Extended Data Fig. 1d) of individual Rubisco-binding regions explains how the pyrenoid 240 
matrix can mix internally on the time scale of seconds5 despite the multivalency of EPYC1. The 241 
even spacing of the five Rubisco-binding regions across EPYC1 is noteworthy and may be an 242 
indication of selective pressure for an optimal distance between binding regions, and thus of an 243 
optimal spacing between Rubisco holoenzymes in the matrix. 244 
Knowledge of the EPYC1-Rubisco binding mechanism now opens doors to the molecular 245 
characterization of the regulation of this interaction, which may govern the dissolution and 246 
condensation of the matrix during cell division5 and in response to environmental factors21. For 247 
example, phosphorylation of EPYC122 may provide a mechanism to rapidly change the binding 248 
affinity of EPYC1 to Rubisco. Inactivation of one Rubisco-binding region on EPYC1 would 249 
yield four binding regions, which would allow two such EPYC1 molecules (each containing four 250 
Rubisco-binding regions, for a total of eight Rubisco-binding regions) to form a mutually 251 
satisfied complex with each Rubisco holoenzyme (containing eight EPYC1-binding sites), a 252 
configuration that is predicted to favor dissolution of the matrix5. 253 
 254 
Our structures explain how other proteins bind to Rubisco  255 
In a parallel study (Meyer et al., please see unpublished manuscript provided as reference 256 
material), we recently discovered that a common sequence motif is present on many pyrenoid-257 
localized proteins. The motif binds Rubisco, enabling recruitment of motif-containing proteins to 258 
the pyrenoid and mediating adhesion between the matrix, pyrenoid tubules, and starch sheath. 259 
This motif, [D/N]W[R/K]XX[L/I/V/A], is present in EPYC1’s Rubisco-binding regions as 260 
defined in the present study, and the motif residues mediate key binding interactions with 261 
Rubisco. In our structures, the R/K of the motif is represented by R64 and K127 of EPYC1, each 262 
of which forms a salt bridge with E24 of the Rubisco small subunit. The XX of the motif almost 263 
always includes a D or E; in our structures this feature is represented by E66 and E129 of 264 
EPYC1, each of which forms a salt bridge with R91 of the Rubisco small subunit. Finally, the W 265 
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and [L/I/V/A] of the motif are represented by W63/W126 and L67/L130 of EPYC1, which 266 
contribute to the hydrophobic interactions with M87, L90 and V94 of the Rubisco small subunit. 267 
The key roles of the motif residues in the interface presented here strongly suggest that the 268 
structures we have obtained for motifs from EPYC1 also explain where and how all other 269 
variants of the motif, including those found on the key pyrenoid proteins SAGA1, SAGA2, 270 
RBMP1, RBMP2 and CSP41A, bind to Rubisco. Our observation that the Rubisco small subunit 271 
D23A/E24A and M87D/V94D mutants exhibit a more severe disruption of the pyrenoid than the 272 
epyc1 mutant10 supports the idea that this region of Rubisco interacts not only with EPYC1, but 273 
also with other proteins required for pyrenoid biogenesis, making this binding interaction a 274 
central hub of pyrenoid biogenesis. 275 
 276 
Structural differences between the pyrenoid and carboxysomes 277 
Although α- and β-carboxysomes are morphologically, functionally and evolutionarily distinct 278 
from the pyrenoid, their Rubisco is also thought to be clustered by linker proteins. Like EPYC1, 279 
the α-carboxysome linker protein CsoS223 is intrinsically disordered and is proposed to bind 280 
Rubisco as an unfolded peptide24. In contrast, the β-carboxysome linker protein CcmM has been 281 
proposed to bind Rubisco using folded globular domains25,26. The use of an unfolded peptide as 282 
in the case of EPYC1 and CsoS2 may provide the benefit of requiring fewer amino acids for 283 
achieving the desired binding function. A notable difference is the location of the binding site on 284 
Rubisco: whereas both carboxysomal linker proteins bind to the interface between two Rubisco 285 
large subunits24,26, EPYC1 binds to the Rubisco small subunit. It remains to be seen whether this 286 
difference in binding site has functional consequences, such as impacts on the three-dimensional 287 
packing of Rubisco. 288 
 289 
Our findings advance the ability to engineer a pyrenoid 290 
There is currently significant interest in engineering Rubisco condensates into 291 
monocotyledonous crops such as wheat and rice to enhance yields27-30. Binding of EPYC1 to the 292 
Rubisco small subunit presents a promising route for engineering a Rubisco condensate, as the 293 
Rubisco small subunit is encoded in the nuclear genome, making it more easily amenable to 294 
genetic modification in those crops than the chloroplast-encoded Rubisco large subunit31. 295 
Knowledge of the binding mechanism now allows engineering of minimal sequence changes into 296 
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native crop Rubiscos to enable binding to EPYC1 and to other key proteins required to 297 
reconstitute a functional pyrenoid. 298 
 299 
Insights into pyrenoid matrix formation in other species 300 
Pyrenoids appear to have evolved independently in different lineages through convergent 301 
evolution7,32. EPYC1, its Rubisco-binding sequences, and the amino acid residues that form the 302 
EPYC1 binding site on the surface of Rubisco are conserved across the order Volvocales, as 303 
evidenced from the genome sequences of Tetrabaena socialis, Gonium pectorale and Volvox 304 
carteri (Supplementary Table 2). While the molecular mechanisms of matrix formation in other 305 
lineages remain to be uncovered, candidate linker proteins have been identified based on 306 
similarity of sequence properties to EPYC110. We hypothesize that the matrix in other lineages is 307 
formed based on similar principles to those we observed in Chlamydomonas. Our experimental 308 
approach for characterizing the binding interaction provides a roadmap for future structural 309 
studies of pyrenoids across the tree of life. 310 
 311 
We provide a structural view of a phase-separated organelle 312 
The pyrenoid matrix presents an unusual opportunity to study a two-component molecular 313 
condensate where one of the components, Rubisco, is large and rigid, and the other component, 314 
EPYC1, is a simple intrinsically disordered protein consisting of nearly identical tandem repeats. 315 
The rigidity and size of Rubisco holoenzymes previously enabled the determination of their 316 
positions and orientations within the pyrenoid matrix of native cells by cryo-electron 317 
tomography5. The identification of EPYC1 binding sites on Rubisco in the present work and the 318 
modeling of linker regions between EPYC1’s Rubisco binding regions now make the 319 
Chlamydomonas pyrenoid matrix one of the most structurally well-defined phase-separated 320 
organelles. Thus, beyond advancing our structural understanding of pyrenoids, organelles that 321 
play a central role in the global carbon cycle, we hope that the findings presented here will also 322 




Strains and culture conditions 326 
Chlamydomonas wild-type (WT) strain cMJ030 was maintained in the dark or low light (~10 327 
μmol photons m-2 s-1) on 1.5% agar plates containing Tris-Acetate-Phosphate medium with 328 
revised trace elements33. For Rubisco extraction, 500 mL Tris-Acetate-Phosphate medium in a 1 329 
L flask was inoculated with a loopful of cells and the culture was grown to 4 x 106 cells/mL at 330 
22°C, shaking at 200 rpm under ~100 μmol photons m-2 s-1 white light in 3% CO2. 331 
Chlamydomonas mutant T60-334 (Δrbcs; containing a deletion of both RBCS genes) was used for 332 
generating Rubisco small subunit point mutants and a wild-type control in the same background. 333 
This strain was maintained on agar in the dark or low light (~10 μmol photons m-2s-1). 334 
 335 
Protein extraction  336 
Rubisco was purified from Chlamydomonas strain cMJ03035. Cells were disrupted by 337 
ultrasonication in lysis buffer (10 mM MgCl2, 50 mM Bicine, 10 mM NaHCO3, 1 mM 338 
dithiothreitol, pH 8.0) supplemented with Halt Protease Inhibitor Cocktail, EDTA-Free (Thermo 339 
Fisher Scientific). The soluble lysate was fractionated by ultracentrifugation on a 10-30% 340 
sucrose gradient in a SW 41 Ti rotor at a speed of 35,000 rpm for 20 hours at 4˚C. Rubisco-341 
containing fractions were applied to an anion exchange column (MONO Q 5/50 GL, GE 342 
Healthcare) and eluted with a linear salt gradient from 30 to 500 mM NaCl in lysis buffer. 343 
 344 
Peptide arrays  345 
Peptide arrays were purchased from the MIT Biopolymers Laboratory (Cambridge, MA). The 346 
tiling array was composed of 18-amino-acid peptides that tiled across the full-length EPYC1 347 
sequence with a step size of one amino acid. Each peptide was represented by at least two spots 348 
on the array, and these replicates were averaged during data analysis. The locations of peptides 349 
on the array were randomized. In the substitution arrays, peptides were designed to represent 350 
every possible one-amino-acid mutation of the indicated region on EPYC1 by substitution with 351 
one of the other 19 amino acids. The arrays were activated by methanol, then washed 3x10 min 352 
in binding buffer (50 mM HEPES, 50 mM KOAc, 2 mM Mg(OAc)2.4H2O, 1 mM CaCl2 and 200 353 
mM sorbitol, pH 6.8). The arrays were then incubated at 4˚C with 1 mg purified Rubisco 354 
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overnight. The arrays were washed in binding buffer to remove any unbound Rubisco. Using a 355 
semi-dry transfer apparatus (BIO-RAD), bound Rubisco was transferred onto an Immobilon-P 356 
PVDF membrane (Millipore Sigma). The Rubisco was detected by one of two methods: western 357 
blotting, or fluorescent labeling. While replicates using the two methods gave similar results, 358 
toward the end of the project we found that fluorescent labeling had a lower background, so we 359 
show fluorescent labeling data in Figure 1; all other data were obtained by western blotting and 360 
chemiluminescence. For fluorescent labeling, Rubisco was labeled with Alexa Fluor™ 680 dye 361 
(Thermo Fisher Scientific) and detected by Typhoon Scanner (GE Healthcare).  For western 362 
blotting, Rubisco was immuno-detected with a polyclonal primary antibody raised against 363 
Rubisco15 (1:10,000) followed by a HRP conjugated goat anti-rabbit (1:20,000; Invitrogen), and 364 
the chemiluminescence was detected by ImageQuant LAS 4000 (GE Healthcare). Images were 365 
analyzed with ImageQuant TL (GE Healthcare). Arrays were stripped with Restore™ Western 366 
Blot Stripping Buffer before re-use (Thermo Fisher Scientific). 367 
For both types of arrays, values for identical sequences present multiple times were 368 
averaged. For tiling arrays, the average value for each sequence was plotted at its position in 369 
EPYC1 (or at multiple positions for sequences present multiple times). For amino acid 370 
substitution arrays, the ratio of each substitution sequence to the corresponding wildtype 371 
sequence was calculated and arrayed by amino acid and position. 372 
 373 
Surface plasmon resonance (SPR) experiments 374 
All the surface preparation experiments were performed at 25˚C using a Biacore 3000 instrument 375 
(GE Healthcare). Purified Rubisco was immobilized on CM5 sensor chips using a Biacore 376 
Amine Coupling Kit according to the manufacturer’s instructions. Briefly, the chip surface was 377 
activated by an injection of 1:1 N-hydroxysuccinimide (NHS)/1-ethyl-3-(3-378 
dimethylaminopropyl)carbodiimide hydrochloride (EDC). Rubisco was diluted to ~100 μg/mL in 379 
10 mM acetate (pH 4.5; this pH had been previously optimized using the immobilization pH 380 
scouting wizard) and was injected over the chip surface. Excess free amine groups were then 381 
capped with an injection of 1 M ethanolamine. Typical immobilization levels were 8,000 to 382 
10,000 resonance units (RU), as recommended for binding experiments of small molecules. For 383 
kinetic experiments (for determining the binding affinities), the typical immobilization levels 384 
were ~5,000 RU. The control surfaces were prepared in exactly the same manner as the 385 
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experimental surfaces except that no Rubisco was injected. For immobilizations, the running 386 
buffer was the Biacore HBS-EP Buffer (0.01 M HEPES pH 7.4, 0.15 M NaCl, 3 mM EDTA, 387 
0.005% v/v Surfactant P20). 388 
All the binding assays were performed using the Biacore PBS-P+ Buffer (20 mM 389 
phosphate buffer, 2.7 mM KCl, 137 mM NaCl and 0.05% Surfactant P20, pH 6.8) as a running 390 
buffer, as recommended for small molecule analysis in Biacore systems. The analytes, consisting 391 
of EPYC1 peptides synthesized by Genscript (Piscataway, New Jersey), were dissolved in the 392 
same running buffer and diluted to 1 mM. The analytes were injected over the control surface 393 
and experimental surfaces at a flow rate of 26 μL/min for 2.5 minutes, followed by 2.5 minutes 394 
of the running buffer alone to allow for dissociation. The surfaces were then regenerated using 395 
running buffer at a flow rate of 30 μL/min for 10 minutes. In all cases, binding to the control 396 
surface was negligible. 397 
For determining the KD of EPYC1 peptide, the kinetic assays were performed with a 398 
running buffer consisting of 200 mM sorbitol, 50 mM HEPES, 50 mM KOAc, 2 mM 399 
Mg(OAc)2•4H2O and 1 mM CaCl2 at pH 6.8 (the same buffer as the peptide array assay). The 400 
EPYC1 peptide was dissolved in the same running buffer as the assay and the serial dilutions 401 
were also made in the same buffer. The analytes were injected over the control surface and 402 
experimental surfaces at a flow rate of 15 μL/min for 2 minutes, followed by 10 minutes with the 403 
running buffer alone to allow for dissociation. The surfaces were then regenerated by the running 404 
buffer at a flow rate of 30 μL/min for 10 minutes. In all cases, binding to the blank chip was 405 
negligible. The fitting and modeling were performed with the BIAevaluation software. 406 
 407 
Single-particle cryo-electron microscopy data collection and image processing 408 
Rubisco and EPYC149-72 peptides with the final concentrations of 1.69 mg/ml (=3.02 µM) and 409 
7.5 mM, respectively, were incubated together on ice for 20 minutes in buffer consisting of 200 410 
mM sorbitol, 50 mM HEPES, 50 mM KOAc, 2 mM Mg(OAc)2•4H2O and 1 mM CaCl2 at pH 6.8 411 
(the same buffer as the peptide array assay and the SPR binding assay). Rubisco and EPYC1106-412 
135 peptides with the final concentrations of 1.75 mg/ml (=3.13 µM) and 10 mM, respectively, 413 
were incubated together on ice for 20 minutes in the same buffer described above. For apo 414 
Rubisco and Rubisco incubated with peptides, similar cryo grid-making procedures were used. 415 
400-mesh Quantifoil 1.2/1.3 Cu grids (Quantifoil, Großlöbichau, Germany) were made 416 
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hydrophilic by glow discharging for 60 seconds with a current of 15 mA in a PELCO easiGlow 417 
system. Cryo grids were produced using a FEI Mark IV Vitrobot (FEI company, part of Thermo 418 
Fisher Scientific, Hillsboro, OR). The chamber of the Vitrobot was kept at 4˚C and 100% 419 
relative humidity. 3 µl of sample was applied to the glow-discharged grid and blotted with filter 420 
paper for 3 seconds with the equipment-specific blotting force set at 3. After blotting, the grid 421 
was rapidly plunge-frozen into a liquid ethane bath.  422 
For apo Rubisco and Rubisco incubated with EPYC149-72 peptide, cryo grids were loaded 423 
into a 300 kV FEI Titan Krios cryo electron microscope (FEI Company) at HHMI Janelia 424 
Research Campus, Janelia Krios2, equipped with a Gatan K2 Summit camera. After initial 425 
screening and evaluation, fully automated data collection was carried out using SerialEM. The 426 
final exposure from each collection target was collected as a movie utilizing dose fractionation 427 
on the K2 Summit camera operated in super-resolution mode. The movies were collected at a 428 
calibrated magnification of 38,168x, corresponding to 1.31 Å per physical pixel in the image 429 
(0.655 Å per super-resolution pixel). The dose rate on the specimen was set to be 5.82 electrons 430 
per Å2 per second and total exposure time was 10 s, resulting in a total dose of 58.2 electrons per 431 
Å2. With dose fractionation set at 0.2 s per frame, each movie series contained 50 frames and 432 
each frame received a dose of 1.16 electrons per Å2. The spherical aberration constant of the 433 
objective lens is 2.7 mm and an objective aperture of 100 µm was used. The nominal defocus 434 
range for the automated data collection was set to be between -1.5 µm and -3.0 µm. For Rubisco 435 
incubated with EPYC1106-135 peptide, the final exposure was collected on Janelia Krios1 436 
equipped with a CS-corrector, a Gatan Bioquantum energy filter and a post-filter K3 camera. The 437 
movies were collected at a nominal magnification of 81,000x, corresponding to 0.844 Å per 438 
physical pixel in the image (0.422 Å per super-resolution pixel). The dose rate on the specimen 439 
was set to be 12 electrons per pixel per second and total exposure time was 3.56 s, resulting in a 440 
total dose of 60 electrons per Å2. Each movie series contained 60 frames and each frame 441 
received a dose of 1 electron per Å2. The nominal defocus range for the automated data 442 
collection was set to be between -1 µm and -1.6 µm. 443 
The movies were 2x binned and motion corrected using MotionCor236 and CTF was 444 
estimated using CTFFIND37 in Relion38. 1,809,869 EPYC149-72 peptide-bound Rubisco particles, 445 
2,257,131 EPYC1106-135 peptide-bound Rubisco particles, and 677,071 Rubisco particles in the 446 
apo state were selected using cisTEM39. 2D classification was performed using cisTEM. The 447 
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classes presenting detailed features in class averages were chosen for 3D classification on 448 
cryoSPARC40,41 and on Relion. The 3D class showing clear secondary structures was chosen for 449 
3D auto-refine first without symmetry and then with D4 symmetry imposed. After CTF 450 
refinement and Bayesian polishing in Relion, the reconstructed map resolution is 2.68 Å for the 451 
apo state, 2.62 Å for the EPYC149-72 peptide-bound state, and 2.06 Å for the EPYC1106-135 452 
peptide-bound state. The EPYC149-72 peptide-bound particles at super-resolution pixel size were 453 
further subjected to CTF refinement and polishing, resulting in map at 2.13 Å resolution. Details 454 
for single-particle cryo-EM data collection and image processing are included in the 455 
Supplementary Table 1.  456 
 457 
Single-particle cryo-electron microscopy model building, fitting, and refinement 458 
A full model for Rubisco from Chlamydomonas was produced from an X-ray structure13 (PDB 459 
entry 1GK8) and used for rigid body fitting into a local resolution filtered apo or EPYC149-72 460 
peptide-bound Rubisco cryo-EM map using UCSF Chimera42. After rigid body fitting of the full 461 
complex, initial flexible fitting was performed in COOT43 by manually going through the entire 462 
peptide chain of a single large and small Rubisco subunit before applying the changes to the 463 
other seven large and small subunits. The C-terminal part of the small subunit was built manually 464 
and the sequences updated to the RBCS2 sequences. The sequence of the EPYC149-72 peptide 465 
was used to predict secondary structure elements using JPred444, which gave the prediction that 466 
the C-terminal region (NWRQELES) is α-helical. Guided by this prediction, the peptide was 467 
built manually into the density using COOT. Additional maps like the initial 2.62 Å from the 468 
binned data and maps filtered to different resolutions with various applied B-factors were also 469 
used to help with model building in unclear regions. Additional real space refinement of the 470 
entire complex was performed using Phenix45. The EPYC1106-135 peptide bound map was used to 471 
build a model of the EPYC1106-135 peptide. First rigid body fitting of the EPYC149-72 peptide-472 
bound Rubisco model into a local resolution filtered EPYC1106-135 peptide-bound Rubisco cryo-473 
EM map was performed using UCSF Chimera. Then the sequence of the peptide was mutated to 474 
the EPYC1106-135 peptide sequence, followed by flexible fitting to slightly adjust the PDB to the 475 
density. Models were subjected to an all-atom structure validation using MolProbity46. Figures 476 
were produced using UCSF Chimera.  477 
 478 
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Liquid–liquid phase separation assay  479 
Proteins used in the liquid–liquid phase separation assay were obtained and stored essentially as 480 
described previously11. Briefly, Rubisco was purified from Chlamydomonas reinhardtii cells 481 
(CC-2677 cw15 nit1-305 mt-5D, Chlamydomonas Resource Center), grown in Sueoka’s high-482 
salt medium47, using a combination of anion exchange chromatography and gel filtration.  483 
The EPYC1 full-length gene (encoding amino acids 1-317) and corresponding R/K 484 
mutant (EPYC1R64A/K127A/K187A/K248A/R314A) were synthesized by GenScript and cloned between 485 
the SacII and HindIII site of the pHue vector48. Proteins were produced in the E. coli strain BL21 486 
(DE3) harbouring pBADESL49 for co-expression of the E. coli chaperonin GroEL/S. The 487 
purification was conducted with minor changes (dialysis for removal of high immidazol 488 
concentrations was skipped by running the gel-filtration column before the second IMAC). After 489 
the first IMAC step and cleavage50 of the N-terminal His6–ubiquitin tag, proteins were separated 490 
by gel filtration. Finally, the peak fraction was passed a second time through an IMAC column, 491 
collecting EPYC1 from the flow through.  492 
EPYC1-Rubisco condensates were reconstituted in vitro in a buffer containing 20 mM 493 
Tris-HCl (pH 8.0) and NaCl concentrations as indicated. 5 µl reactions were incubated for 3 494 
minutes at room temperature before monitoring the droplet formation by differential interference 495 
contrast (DIC) microscopy. DIC images were acquired with a Nikon Eclipse Ti Inverted 496 
Microscope using a 60× oil-immersion objective after allowing the droplets to settle on the 497 
coverslip (Superior Marienfeld, Germany) surface for about 3 minutes. For droplet sedimentation 498 
assays 10 µl reactions were incubated for 3 minutes at 20°C before separating the droplets form 499 
the bulk phase by spinning for 3 minutes at 21,000xg and 4°C. Pelleted droplets and supernatant 500 
fractions were analyzed using Coomassie-stained SDS-PAGE. 501 
 502 
Yeast two-hybrid assay  503 
Yeast two-hybrid to detect interactions between EPYC1 and RbcS1 was carried out as described 504 
previously12. EPYC1 was cloned into the two-hybrid vector pGBKT7 to create a fusion with the 505 
GAL4 DNA binding domain. Point mutations were introduced by PCR into RbcS1, which was 506 
then cloned in the pGADT7 to create a fusion with the GAL4 activation domain. Yeast cells 507 
were then co-transformed with binding and activation domain vectors. Successful transformants 508 
were cultured, diluted to an optical density at 600 nm (OD600) of 0.5 or 0.1, and plated onto SD-509 
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L-W and SD-L-W-H containing increasing concentrations of the HIS3 inhibitor triaminotriazole 510 
(3-AT). Plates were imaged after 3 days. Spots shown in Fig. 5a were grown at 5 mM 3-AT from 511 
a starting OD600 of 0.5; they are a subset of the full dataset shown in Extended Data Fig. 6. 512 
 513 
Cloning of Rubisco small subunit point mutants 514 
The plasmid pSS1-ITP51 which contains Chlamydomonas RBCS1 including UTRs and introns 1 515 
and 2 was used as a starting point for generating plasmids pSH001 and pSH002, which encode 516 
RBCS1D23A/E24A, and RBCS1M87D/V94D, respectively. The point mutations were generated by 517 
Gibson assembly52 of gBlocks (synthesized by Integrated DNA Technologies) containing the 518 
desired mutations into pSS-ITP that had been enzyme digested by restriction endonucleases 519 
(XcmI and BbvCI for the D23A/E24A mutations and BbvCI and BlpI for the M87D/V94D 520 
mutations). All constructs were verified by Sanger sequencing. 521 
The fragment for making pSH001 (containing the D23A/E24A Rubisco small subunit 522 





The fragment for making pSH002 (containing the M87D/V94D Rubisco small subunit 528 









 Both the plasmids pSH001 and pSH002 have been submitted to the Chlamydomonas 538 
Resource Center (www.chlamycollection.org). 539 
 540 
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Transformation of Chlamydomonas to make the Rubisco small subunit point mutants 541 
Chlamydomonas strains Δrbcs;RBCSWT, Δrbcs;RBCSD23A/E24A, and Δrbcs;RBCSM87D/V94D (The 542 
accession numbers of these strains in Chlamydomonas Resource Center are CC-5616, CC-5617 543 
and CC-5618, respectively.) were generated by transforming pSS1-ITP, pSH001, and pSH002 544 
(encoding Rubisco small subunit constructs) into the Rubisco small subunit deletion mutant T60 545 
(Δrbcs) by electroporation as described previously53. For each transformation, 29 ng kbp-1 of 546 
KpnI linearized plasmid was mixed with 250 μL of 2 x 108 cells mL-1 at 16°C and electroporated 547 
immediately. Transformant colonies were selected on Tris-Phosphate plates without antibiotics 548 
at 3% v/v CO2 under ~50 μmol photons m
-2 s-1 light. The sequence of RbcS in the transformants 549 
was verified by PCR amplification and Sanger sequencing. 550 
 551 
Spot tests 552 
 Δrbcs;RBCSWT, Δrbcs;RBCSD23A/E24A, and Δrbcs;RBCSM87D/V94D (The accession numbers of these 553 
strains in Chlamydomonas Resource Center are CC-5616, CC-5617 and CC-5618, respectively.) 554 
were grown in Tris-Phosphate medium at 3% CO2 until ~2x10
6 cells mL-1. Cells were diluted in 555 
Tris-Phosphate medium to a concentration of 8.7 x107 cells mL-1, then serially diluted 1:10 three 556 
times. 7.5 μL of each dilution was spotted onto four TP plates and incubated in air or 3% CO2 557 
under 20 or 100 μmol photons m-2 s-1 white light for 9 days before imaging. 558 
 559 
Transmission electron microscopy  560 
Samples for electron microscopy were fixed for 1 hour at room temperature in 2.5% 561 
glutaraldehyde in Tris-Phosphate medium (pH 7.4), followed by 1 hour at room temperature in 562 
1% OsO4, 1.5% K3Fe(CN)3, and 2 mM CaCl2. Fixed cells were then bulk stained for 1 hour in 563 
2% uranyl acetate, 0.05 M maleate buffer at pH 5.5. After serial dehydration (50%, 75%, 95%, 564 
and 100% ethanol, followed by 100% acetonitrile), samples were embedded in epoxy resin 565 
containing 34% Quetol 651, 44% nonenyl succinic anhydride, 20% methyl-5- norbornene-2,3-566 
dicarboxylic anhydride, and 2% catalyst dimethylbenzylamine. Ultramicrotomy was done by the 567 
Core Imaging Lab, Medical School, Rutgers University. Imaging was performed at the Imaging 568 
and Analysis Center, Princeton University, on a CM100 transmission electron microscope 569 
(Philips, Netherlands) at 80 kV. 570 
 571 
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Measurement of nearest-neighbor distances between EPYC1 binding sites on Rubisco 572 
holoenzymes within pyrenoids 573 
For detailed descriptions of the Chlamydomonas cell culture, vitrification of cells onto EM grids, 574 
thinning of cells by cryo-focused ion beam milling, 3D imaging of native pyrenoids by cryo-575 
electron tomography, tomographic reconstruction, template matching, and subtomogram 576 
averaging, see our previous study5. In that study, we measured the distances between the center 577 
positions of Rubisco complexes within tomograms of five pyrenoids. The spatial parameters 578 
determined in that study were combined with the EPYC1-binding sites resolved here by cryo-579 
EM single-particle analysis to measure the nearest-neighbor distances between EPCY1 binding 580 
sites on adjacent Rubisco complexes within the native pyrenoid matrix. 581 
The in situ subtomogram average EMD-36945 was used as the reference for the Rubisco 582 
model. We extracted the isosurface from this density using the 0.5 contour level recommended in 583 
the Electron Microscopy Data Bank entry. We then fit the atomic model of EPYC1-bound 584 
Rubisco (Fig. 2) within the EMD-3694 density, and for each EPYC1 binding site, we marked the 585 
closest point on the isosurface to define the EPYC1 binding sites on this model. The positions 586 
and orientations previously determined by subtomogram averaging were used to place each 587 
Rubisco model and its corresponding binding sites into the pyrenoid tomograms using the PySeg 588 
program54. 589 
To compute the nearest-neighbor distances between EPYC1 binding sites on two 590 
different Rubisco complexes, first, linkers were drawn between each EPYC1 binding site and all 591 
other binding sites within 25 nm. Binding sites on the same Rubisco complex were ignored. 592 
Next, the linkers were filtered by length (defined as the Euclidean distance between the two 593 
binding sites), and only the shortest linker was retained for each binding site. To prevent edge 594 
effects, linkers were discarded if they had a binding site <12 nm from the masked excluded 595 
volume (grey in Fig. 6b), which marks the border of the analyzed pyrenoid matrix. Finally, linker 596 
distances were plotted in a histogram to show the distribution of lengths (normalized to 100%). 597 
Regarding the accuracy of the Rubisco localization in the previous study5, we used 598 
template matching, subtomogram alignment, and hierarchical classification to identify 97.5% of 599 
the Rubisco complexes in each of the five pyrenoid volumes. The Rubisco average was 600 
determined at a resolution of 16.5 Å. This could be interpreted to mean that the Rubisco 601 
complexes were localized with 1.65 nm precision. However, this resolution is not a simple 602 
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reflection of translational and rotational accuracy, but is also greatly limited by the contrast 603 
transfer function and pixel size of the tomographic data. Furthermore, with this localization 604 
uncertainty being random for each particle, it would not change the ~4 nm peak distance between 605 
neighboring EPYC1 binding sites measured in our current study. 606 
 607 
Modeling of the energy required to stretch EPYC1-linker regions 608 
The energy required to stretch the linker regions between EPYC1’s Rubisco-binding regions was 609 
determined as follows. The force F required to stretch a 40 amino acid linker region to any given 610 
length z was approximated using a wormlike chain model55: 611 ( ) = 4 1(1 − / ) − 1 + 4  
In the above equation, kB is the Boltzmann constant, T is the temperature, Lp is the persistence 612 
length (assumed to be 1 nm, a representative value for disordered proteins), and L0 is the contour 613 
length (estimated as 40 amino acids * 0.36 nm/amino acid). The energy required to stretch the 614 
linker to a length x is given by: 615 ( ) = ( )  
This energy was calculated and plotted in Fig. 6d. 616 
617 
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Data availability 618 
All data generated or analyzed during this study are included in this Article, the Extended Data 619 
and the Supplementary tables. The single-particle cryo-EM maps have been deposited in the 620 
Electron Microscopy Data Bank with accession codes EMDB-22401, EMDB-22308 and EMDB-621 
22462. The atomic models have been deposited in the Protein Data Bank under accession codes 622 
PDB 7JN4, PDB 7JFO and PDB 7JSX. The raw datasets have been deposited in the Electron 623 
Microscopy Public Image Archive with accession codes EMPIAR-10503, EMPIAR-10502 and 624 
EMPIAR-10501. The subtomogram average of Rubisco has been deposited in the Electron 625 




1 Field, C. B., Behrenfeld, M. J., Randerson, J. T. & Falkowski, P. Primary production of 629 
the biosphere: integrating terrestrial and oceanic components. Science 281, 237-240 630 
(1998). 631 
2 Hessler, A. M., Lowe, D. R., Jones, R. L. & Bird, D. K. A lower limit for atmospheric 632 
carbon dioxide levels 3.2 billion years ago. Nature 428, 736-738 (2004). 633 
3 Ainsworth, E. A. & Long, S. P. What have we learned from 15 years of free-air CO2 634 
enrichment (FACE)? A meta-analytic review of the responses of photosynthesis, canopy 635 
properties and plant production to rising CO2. New Phytol 165, 351-371, 636 
doi:10.1111/j.1469-8137.2004.01224.x (2005). 637 
4 Raven, J. A., Cockell, C. S. & De La Rocha, C. L. The evolution of inorganic carbon 638 
concentrating mechanisms in photosynthesis. Philosophical transactions of the Royal 639 
Society of London. Series B, Biological sciences 363, 2641-2650, 640 
doi:10.1098/rstb.2008.0020 (2008). 641 
5 Freeman Rosenzweig, E. S. et al. The Eukaryotic CO2-Concentrating Organelle Is 642 
Liquid-like and Exhibits Dynamic Reorganization. Cell 171, 148-162 e119, 643 
doi:10.1016/j.cell.2017.08.008 (2017). 644 
6 Badger, M. R. et al. The diversity and coevolution of Rubisco, plastids, pyrenoids, and 645 
chloroplast-based CO2-concentrating mechanisms in algae. Can J Bot 76, 1052–1071, 646 
doi:10.1139/b98-074 (1998). 647 
7 Villarreal, J. C. & Renner, S. S. Hornwort pyrenoids, carbon-concentrating structures, 648 
evolved and were lost at least five times during the last 100 million years. Proc Natl Acad 649 
Sci U S A 109, 18873-18878, doi:10.1073/pnas.1213498109 (2012). 650 
8 Wang, Y., Stessman, D. J. & Spalding, M. H. The CO2 concentrating mechanism and 651 
photosynthetic carbon assimilation in limiting CO2 : how Chlamydomonas works against 652 
the gradient. The Plant journal : for cell and molecular biology 82, 429-448, 653 
doi:10.1111/tpj.12829 (2015). 654 
9 Raven, J. A. CO2-concentrating mechanisms: A direct role for thylakoid lumen 655 
acidification? Plant Cell Environ 20, 147-154, doi:Doi 10.1046/J.1365-3040.1997.D01-656 
67.X (1997). 657 
10 Mackinder, L. C. et al. A repeat protein links Rubisco to form the eukaryotic carbon-658 
concentrating organelle. Proc Natl Acad Sci U S A 113, 5958-5963, 659 
doi:10.1073/pnas.1522866113 (2016). 660 
 30
11 Wunder, T., Cheng, S. L. H., Lai, S. K., Li, H. Y. & Mueller-Cajar, O. The phase 661 
separation underlying the pyrenoid-based microalgal Rubisco supercharger. Nature 662 
communications 9, 5076, doi:10.1038/s41467-018-07624-w (2018). 663 
12 Atkinson, N. et al. The pyrenoidal linker protein EPYC1 phase separates with hybrid 664 
Arabidopsis-Chlamydomonas Rubisco through interactions with the algal Rubisco small 665 
subunit. Journal of experimental botany 70, 5271-5285, doi:10.1093/jxb/erz275 (2019). 666 
13 Taylor, T. C., Backlund, A., Bjorhall, K., Spreitzer, R. J. & Andersson, I. First crystal 667 
structure of Rubisco from a green alga, Chlamydomonas reinhardtii. J Biol Chem 276, 668 
48159-48164, doi:10.1074/jbc.M107765200 (2001). 669 
14 Duff, A. P., Andrews, T. J. & Curmi, P. M. The transition between the open and closed 670 
states of rubisco is triggered by the inter-phosphate distance of the bound bisphosphate. J 671 
Mol Biol 298, 903-916, doi:10.1006/jmbi.2000.3724 (2000). 672 
15 Meyer, M. T. et al. Rubisco small-subunit α-helices control pyrenoid formation in 673 
Chlamydomonas. Proc Natl Acad Sci U S A 109, 19474-19479, 674 
doi:10.1073/pnas.1210993109. (2012). 675 
16 Engel, B. D. et al. Native architecture of the Chlamydomonas chloroplast revealed by in 676 
situ cryo-electron tomography. eLife 4, DOI: 10.7554/eLife.04889, 677 
doi:10.7554/eLife.04889 (2015). 678 
17 Goodenough, U. W. & Levine, R. P. Chloroplast structure and function in ac-20, a 679 
mutant strain of Chlamydomonas reinhardi. 3. Chloroplast ribosomes and membrane 680 
organization. J Cell Biol. 44, 547-562, doi:10.1083/jcb.44.3.547 (1970). 681 
18 Ma, Y., Pollock, S. V., Xiao, Y., Cunnusamy, K. & Moroney, J. V. Identification of a 682 
novel gene, CIA6, required for normal pyrenoid formation in Chlamydomonas 683 
reinhardtii. Plant Physiol 156, 884-896, doi:10.1104/pp.111.173922 (2011). 684 
19 Caspari, O. D. et al. Pyrenoid loss in Chlamydomonas reinhardtii causes limitations in 685 
CO2 supply, but not thylakoid operating efficiency. Journal of experimental botany 68, 686 
3903-3913, doi:10.1093/jxb/erx197 (2017). 687 
20 Li, P. et al. Phase transitions in the assembly of multivalent signalling proteins. Nature 688 
483, 336-340, doi:10.1038/nature10879 (2012). 689 
21 Borkhsenious, O. N., Mason, C. B. & Moroney, J. V. The Intracellular Localization of 690 
Ribulose-1,5-Bisphosphate Carboxylase/Oxygenase in Chlamydomonas reinhardtii. Plant 691 
Physiol 116, 1585–1591, doi:10.1104/pp.116.4.1585 (1998). 692 
22 Turkina, M. V., Blanco-Rivero, A., Vainonen, J. P., Vener, A. V. & Villarejo, A. CO2 693 
limitation induces specific redox-dependent protein phosphorylation in Chlamydomonas 694 
reinhardtii. Proteomics 6, 2693-2704, doi:10.1002/pmic.200500461 (2006). 695 
 31
23 Cai, F. et al. Advances in Understanding Carboxysome Assembly in Prochlorococcus and 696 
Synechococcus Implicate CsoS2 as a Critical Component. Life (Basel) 5, 1141-1171, 697 
doi:10.3390/life5021141 (2015). 698 
24 Oltrogge, L. M. et al. Multivalent interactions between CsoS2 and Rubisco mediate 699 
alpha-carboxysome formation. Nat Struct Mol Biol 27, 281-287, doi:10.1038/s41594-700 
020-0387-7 (2020). 701 
25 Long, B. M., Badger, M. R., Whitney, S. M. & Price, G. D. Analysis of carboxysomes 702 
from Synechococcus PCC7942 reveals multiple Rubisco complexes with carboxysomal 703 
proteins CcmM and CcaA. J Biol Chem 282, 29323-29335, doi:10.1074/jbc.M703896200 704 
(2007). 705 
26 Wang, H. et al. Rubisco condensate formation by CcmM in beta-carboxysome 706 
biogenesis. Nature 566, 131-135, doi:10.1038/s41586-019-0880-5 (2019). 707 
27 Hennacy, J. H. & Jonikas, M. C. Prospects for Engineering Biophysical CO2 708 
Concentrating Mechanisms into Land Plants to Enhance Yields. Annual review of plant 709 
biology, doi:10.1146/annurev-arplant-081519-040100 (2020). 710 
28 Long, B. M. et al. Carboxysome encapsulation of the CO2-fixing enzyme Rubisco in 711 
tobacco chloroplasts. Nature communications 9, 3570, doi:10.1038/s41467-018-06044-0 712 
(2018). 713 
29 Lin, M. T., Occhialini, A., Andralojc, P. J., Parry, M. A. & Hanson, M. R. A faster 714 
Rubisco with potential to increase photosynthesis in crops. Nature 513, 547-550, 715 
doi:10.1038/nature13776 (2014). 716 
30 Atkinson, N. et al. Introducing an algal carbon-concentrating mechanism into higher 717 
plants: location and incorporation of key components. Plant Biotechnol J 14, 1302-1315, 718 
doi:10.1111/pbi.12497 (2016). 719 
31 Hanson, M. R., Gray, B. N. & Ahner, B. A. Chloroplast transformation for engineering of 720 
photosynthesis. Journal of experimental botany 64, 731-742, doi:10.1093/jxb/ers325 721 
(2013). 722 
32 Raven, J. A., Beardall, J. & Sanchez-Baracaldo, P. The possible evolution and future of 723 
CO2-concentrating mechanisms. J Exp Bot 68, 3701-3716, doi:10.1093/jxb/erx110 724 
(2017). 725 
33 Kropat, J. et al. A revised mineral nutrient supplement increases biomass and growth rate 726 
in Chlamydomonas reinhardtii. The Plant journal : for cell and molecular biology 66, 727 
770-780, doi:10.1111/j.1365-313X.2011.04537.x (2011). 728 
34 Khrebtukova, I. & Spreitzer, R. J. Elimination of the Chlamydomonas gene family that 729 
encodes the small subunit of ribulose-1,5-bisphosphate carboxylase/oxygenase. Proc Natl 730 
Acad Sci U S A 93, 13689–13693, doi:10.1073/pnas.93.24.13689 (1996). 731 
 32
35 Zhang, R. et al. High-Throughput Genotyping of Green Algal Mutants Reveals Random 732 
Distribution of Mutagenic Insertion Sites and Endonucleolytic Cleavage of Transforming 733 
DNA. Plant Cell 26, 1398-1409, doi:10.1105/tpc.114.124099 (2014). 734 
36 Zheng, S. Q. et al. MotionCor2: anisotropic correction of beam-induced motion for 735 
improved cryo-electron microscopy. Nat Methods 14, 331-332, doi:10.1038/nmeth.4193 736 
(2017). 737 
37 Rohou, A. & Grigorieff, N. CTFFIND4: Fast and accurate defocus estimation from 738 
electron micrographs. J Struct Biol 192, 216-221, doi:10.1016/j.jsb.2015.08.008 (2015). 739 
38 Zivanov, J. et al. New tools for automated high-resolution cryo-EM structure 740 
determination in RELION-3. eLife 7, doi:10.7554/eLife.42166 (2018). 741 
39 Grant, T., Rohou, A. & Grigorieff, N. cisTEM, user-friendly software for single-particle 742 
image processing. eLife 7, doi:10.7554/eLife.35383 (2018). 743 
40 Punjani, A., Rubinstein, J. L., Fleet, D. J. & Brubaker, M. A. cryoSPARC: algorithms for 744 
rapid unsupervised cryo-EM structure determination. Nat Methods 14, 290-296, 745 
doi:10.1038/nmeth.4169 (2017). 746 
41 Punjani, A., Brubaker, M. A. & Fleet, D. J. Building Proteins in a Day: Efficient 3D 747 
Molecular Structure Estimation with Electron Cryomicroscopy. IEEE Trans Pattern Anal 748 
Mach Intell 39, 706-718, doi:10.1109/TPAMI.2016.2627573 (2017). 749 
42 Pettersen, E. F. et al. UCSF Chimera--a visualization system for exploratory research and 750 
analysis. J Comput Chem 25, 1605-1612, doi:10.1002/jcc.20084 (2004). 751 
43 Emsley, P., Lohkamp, B., Scott, W. G. & Cowtan, K. Features and development of Coot. 752 
Acta Crystallogr D Biol Crystallogr 66, 486-501, doi:10.1107/S0907444910007493 753 
(2010). 754 
44 Drozdetskiy, A., Cole, C., Procter, J. & Barton, G. J. JPred4: a protein secondary 755 
structure prediction server. Nucleic Acids Res 43, W389-394, doi:10.1093/nar/gkv332 756 
(2015). 757 
45 Adams, P. D. et al. PHENIX: a comprehensive Python-based system for macromolecular 758 
structure solution. Acta Crystallogr D Biol Crystallogr 66, 213-221, 759 
doi:10.1107/S0907444909052925 (2010). 760 
46 Chen, V. B. et al. MolProbity: all-atom structure validation for macromolecular 761 
crystallography. Acta Crystallogr D Biol Crystallogr 66, 12-21, 762 
doi:10.1107/S0907444909042073 (2010). 763 
47 Sueoka, N. Mitotic replication of deoxyribonucleic acid in Chlamydomonas reinhardi. 764 
Proc Natl Acad Sci U S A. 46, 83–91, doi:10.1073/pnas.46.1.83 (1960). 765 
 33
48 Catanzariti, A. M., Soboleva, T. A., Jans, D. A., Board, P. G. & Baker, R. T. An efficient 766 
system for high-level expression and easy purification of authentic recombinant proteins. 767 
Protein Sci 13, 1331-1339, doi:10.1110/ps.04618904 (2004). 768 
49 Ewalt, K. L., Hendrick, J. P., Houry, W. A. & Hartl, F. U. In vivo observation of 769 
polypeptide flux through the bacterial chaperonin system. Cell 90, 491-500, 770 
doi:10.1016/s0092-8674(00)80509-7 (1997 ). 771 
50 Baker, R. T. et al. in Ubiquitin and Protein Degradation, Part A  Methods in Enzymology   772 
540-554 (2005). 773 
51 Genkov, T., Meyer, M., Griffiths, H. & Spreitzer, R. J. Functional hybrid rubisco 774 
enzymes with plant small subunits and algal large subunits: engineered rbcS cDNA for 775 
expression in chlamydomonas. J Biol Chem 285, 19833-19841, 776 
doi:10.1074/jbc.M110.124230 (2010). 777 
52 Gibson, D. G. et al. Enzymatic assembly of DNA molecules up to several hundred 778 
kilobases. Nature methods 6, 343-345, doi:10.1038/nmeth.1318 (2009). 779 
53 Li, X. et al. A genome-wide algal mutant library and functional screen identifies genes 780 
required for eukaryotic photosynthesis. Nat Genet 51, 627-635, doi:10.1038/s41588-019-781 
0370-6 (2019). 782 
54 Martinez-Sanchez, A. et al. Template-free detection and classification of membrane-783 
bound complexes in cryo-electron tomograms. Nat Methods, doi:10.1038/s41592-019-784 
0675-5 (2020). 785 
55 Cheng, S., Cetinkaya, M. & Grater, F. How sequence determines elasticity of disordered 786 




We thank Jianping Wu, Nieng Yan, Luke Mackinder, Cliff Brangwynne and members of the 791 
Jonikas laboratory for helpful discussions; Ned Wingreen, Silvia Ramundo, Jessi Hennacy, Eric 792 
Franklin and Alexandra Wilson for constructive feedback on the manuscript; Wolfgang 793 
Baumeister and Jürgen Plitzko for providing support and cryo-ET instrumentation; and 794 
Miroslava Schaffer for help with acquiring the cryo-ET data, previously published in Freeman 795 
Rosenzweig et al., 2017. This project was funded by National Science Foundation (IOS-1359682 796 
and MCB-1935444), National Institutes of Health (DP2-GM-119137), and Simons Foundation 797 
and Howard Hughes Medical Institute (55108535) grants to M.C.J., Deutsche 798 
Forschungsgemeinschaft grant (EN 1194/1-1 as part of FOR2092) to B.D.E., Ministry of 799 
 34
Education (MOE Singapore) Tier 2 grant (MOE2018-T2-2-059) to O.M.-C., UK Biotechnology 800 
and Biological Sciences Research Council (BB/S015531/1) and Leverhulme Trust (RPG-2017-801 
402) grants to A.J.M and N.A., NIH grant R01GM071574 to F.M.H., Deutsche 802 
Forschungsgemeinschaft fellowship (PO2195/1-1) to S.A.P., and National Institute of General 803 
Medical Sciences of the National Institutes of Health (T32GM007276) training grant to V.K.C.. 804 
The content is solely the responsibility of the authors and does not necessarily represent the 805 
official view of the National Institutes of Health. 806 
 807 
Author contributions 808 
S.H., P.D.J., V.C., F.M.H., T.W., O.M.-C., B.D.E., and M.C.J. designed experiments. S.H. 809 
identified EPYC1’s Rubisco-binding regions on EPYC1 by peptide tiling array and SPR. S.H. 810 
and S.A.P. prepared the Rubisco and EPYC1 peptide sample for single-particle cryo-EM; S.H., 811 
S.A.P. and G.H. prepared the Rubisco samples for peptide tiling array and surface plasmon 812 
resonance. H.-T.C., D.M. and Z.Y. performed Cryo-EM grid preparation, sample screening, data 813 
acquisition, image processing, reconstruction and map generation. D.M. and P.D.J. carried out 814 
single-particle model building and fitting and refinement. S.H., H.-T.C., D.M., P.D.J., F.M.H. 815 
and M.C.J. analyzed the structures. S.H. and W.P. analyzed EPYC1 binding to Rubisco by 816 
peptide substitution array and SPR. T.W. performed in vitro reconstitution phase separation 817 
experiments. N.A. and A.J.M. performed yeast two-hybrid experiments. S.H. and M.T.M. made 818 
Rubisco small subunit point mutants. S.H. performed spot test experiments. M.T.M. performed 819 
TEM. A.M.-S. performed the cryo-ET data analysis and modeling. S.H. and M.C.J. wrote the 820 
manuscript. All authors read and commented on the manuscript. 821 
 822 
Conflict of interest statement 823 
Princeton University and HHMI have submitted a provisional patent application on aspects of 824 
the findings.  825 
 35
Figures  826 
 827 
Fig. 1 | EPYC1 consists of five tandem sequence repeats, each of which contains a Rubisco-828 
binding region. a, A representative (N=15) transmission electron microscopy (TEM) image of a 829 
Chlamydomonas cell. Scale bar = 1 μm. b, Cartoon depicting the chloroplast and pyrenoid in the 830 
image shown in panel a. The blue dots indicate the location of Rubisco enzymes clustered in the 831 
pyrenoid matrix. c, We hypothesized that pyrenoid matrix formation is mediated by multivalent 832 
interactions between Rubisco and the intrinsically disordered protein EPYC1. d, We designed an 833 
array of 18 amino acid peptides tiling across the full length EPYC1 sequence. e, Incubation of 834 
the array with purified Rubisco allows identification of peptides that bind to Rubisco. f, Image of 835 
the Rubisco binding signal from the peptide tiling array. g, The Rubisco binding signal was 836 
quantified and plotted for each peptide as a function of the position of the middle of the peptide 837 
along the EPYC1 sequence. The initial 26 amino acids of EPYC1 correspond to a chloroplast 838 
targeting peptide (cTP), which is not present in the mature protein12. Results are representative of 839 
three independent experiments. h, The positions of EPYC1’s five sequence repeats are shown to 840 
scale with panel g. Predicted α-helical regions are shown as wavy lines. i, Primary sequence of 841 
EPYC1, with the five sequence repeats aligned. In panels h and i, the regions represented by 842 
peptides subsequently used for structural studies are underlined with red lines (EPYC149-72) and 843 
pink lines (EPYC1106-135). EPYC1106-135 is an exact match to the underlined sequence of Repeats 844 
2 and 4, and has a one-amino acid difference from the corresponding region in Repeat 3 (dashed 845 
underline).  846 
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Fig. 2 | EPYC1 binds to Rubisco small subunits. a, Peptide EPYC149-72, corresponding to the 847 
first Rubisco-binding region of EPYC1, was incubated at saturating concentrations with Rubisco 848 
prior to single-particle cryo-electron microscopy. b-e, Density maps (b, d) and cartoons (c, e) 849 
illustrate the side views (b, c) and top views (d, e) of the density map of the EPYC1 peptide-850 
Rubisco complex. Dashed boxes in panel b indicate regions shown in Fig. 3a-f. 851 
  852 
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Fig. 3 | EPYC1 binds to Rubisco small subunit α-helices via salt bridges and a hydrophobic 853 
pocket. a-b, Front (a) and side (b) views of the EPYC149-72 peptide (red) bound to the two ⍺-854 
helices of the Rubisco small subunit (blue). c-d, Three pairs of residues form salt bridges 855 
between the helix of the EPYC149-72 peptide and the helices on the Rubisco small subunit. Shown 856 
are front (c) and side (d) views as in panel a and panel b. The distances from EPYC1 R64, R71 857 
and E66 to Rubisco small subunit E24, D23 and R91 are 3.06 , 2.78 , and 2.79 , 858 
respectively. e-f, A hydrophobic pocket is formed by three residues of the EPYC149-72 peptide 859 
and three residues of helix B of the Rubisco small subunit. Shown are front (e) and side (f) views 860 
as in panel a and panel b. g, Summary of the interactions observed between the EPYC149-72 861 
peptide and the two α-helices of the Rubisco small subunit. Helices are highlighted; the residues 862 
mediating interactions are bold; salt bridges are shown as dotted lines; residues contributing to 863 
the hydrophobic pocket are shown in black.  864 
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Fig. 4 | Interface residues on EPYC1 are required for binding and phase separation of 865 
EPYC1 and Rubisco in vitro. a, Rubisco binding to a peptide array representing every possible 866 
single amino acid substitution for amino acids 56-71 of EPYC1. The binding signal was 867 
normalized by the binding signal of the original sequence. b, The effect of mutating the central R 868 
or K in each of EPYC1’s Rubisco-binding regions on in vitro phase separation of EPYC1 with 869 
Rubisco. Scale bar = 10 μm. For each condition, the experiment was performed twice 870 
independently with similar results.   871 
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Fig. 5 | Interface residues on Rubisco are required for yeast two-hybrid interactions 872 
between EPYC1 and Rubisco, and for pyrenoid matrix formation in vivo. a, The importance 873 
of Rubisco small subunit residues for interaction with EPYC1 was tested by mutagenesis in a 874 
yeast two-hybrid experiment. b, The Rubisco small subunit-less mutant T60 (Δrbcs) was 875 
transformed with wild-type, D23A/E24A or M87D/V94D Rubisco small subunits. Serial 1:10 876 
dilutions of cell cultures were spotted on TP minimal medium and grown in air or 3% CO2. c-d, 877 
Representative electron micrographs of whole cells (c) and corresponding pyrenoids (d) of the 878 
strains expressing wild-type, D23A/E24A, and M87D/V94D Rubisco small subunit. Dashes in 879 
panel c indicate regions shown in panel d. Scale bars = 500 nm. At least 25 cells were imaged for 880 
each strain; additional representative images are shown in Extended Data Fig. 10c.  881 
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Fig. 6 | A model for matrix structure consistent with in situ Rubisco positions and 882 
orientations. a, The pyrenoid matrix was imaged by cryo-electron tomography5. An individual 883 
slice through the three-dimensional volume is shown. Scale bar = 200 nm. b, The positions and 884 
orientations of individual Rubisco holoenzymes (blue) were determined with high sensitivity and 885 
specificity (97.5% positive identification) by template matching, subtomogram averaging, and 886 
classification and then mapped back into the tomogram volume shown in panel a. The yellow 887 
box indicates the region shown in panel c. Scale bar = 200 nm. c, The distances (yellow) between 888 
the nearest EPYC1-binding sites (red) on neighboring Rubisco holoenzymes (blue) were 889 
measured. The view is from inside the matrix; in some cases the nearest EPYC1 binding site is 890 
on a Rubisco that is out of the field of view, causing some yellow lines to appear unconnected in 891 
this image. Scale bar = 20 nm. The data shown in panels a-c are representative of the five 892 
independent tomograms used for this study. d, Histogram showing the distances between the 893 
nearest EPYC1 binding sites on neighboring Rubisco holoenzymes. The black line indicates the 894 
median, and the yellow shading indicates 95% confidence interval based on data from five 895 
independent tomograms. The estimated energy required for stretching a chain of 40 amino acids 896 
a given distance is shown in blue. e, A 3D model illustrates how EPYC1 (red) could crosslink 897 
multiple Rubisco holoenzymes (blue) to form the pyrenoid matrix. The conformations of the 898 
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Extended Data Fig. 1 The EPYC1 peptides with 
the highest binding 
affinities to Rubisco 




a, Diagram indicating the differences between the previously 
defined sequence repeats10 and the newly defined sequence 
repeats on full-length EPYC1. b, To verify the Rubisco-binding 
regions on EPYC1, surface plasmon resonance (SPR) was used 
to measure the binding of EPYC1 peptides to Rubisco. Purified 
Rubisco was immobilized on a sensor surface, and the EPYC1 
peptides in solution were injected over the surface. The 
binding activity was recorded in real time in a sensorgram. c, 
The peptides used in SPR experiments are shown aligned to 
the sequence as shown in Fig. 1. The Rubisco-binding signal 
from the SPR experiment of each peptide is shown after 
normalization to the peptide’s molecular weight. EPYC149-72 
(boxed in red) and EPYC1106-135 (boxed in pink) were chosen for 
structural studies based on their reproducible high Rubisco 
binding signal. d, The Rubisco-binding response of the EPYC149-
72 peptide at different concentrations was measured by SPR. e, 
The binding responses shown in (d) were fitted to estimate 
the KD of EPYC149-72 peptide binding to Rubisco. Extended Data Fig. 2 Single-particle cryo-EM 





a-c, Representative micrographs of the apo Rubisco sample 
(a), the Rubisco-EPYC149-72 complex (b) and the Rubisco-
EPYC1106-135 complex (c). Scale bars = 100 nm. d-f, 
Representative 2D class averages of the apo Rubisco sample 
(d), the Rubisco-EPYC149-72 complexes (e) and the Rubisco-
 2
EPYC1106-135 complexes (f). g-i, Overview of the workflow for 
single-particle data processing for the apo Rubisco sample (g), 
the Rubisco-EPYC149-72 sample (h) and the Rubisco-EPYC1106-135 
sample (i). j-l, Local resolution estimation of the final refined 
apo Rubisco map (j), the final refined Rubisco-EPYC149-72 
complex map (k) and the final refined Rubisco-EPYC1106-135 
complex map (l). Extended Data Fig. 3 Cryo-EM analysis and 
resolution of apo 
Rubisco and Rubisco-
EPYC1 peptide 
complexes in this study. 
Extended_Data_Fig. 
3-20200728.jpg 
a-b, Representative cryo-EM density quality showing an α-
helix of residues 214-232 in chain A (one of the Rubisco large 
subunits) (a) and a β-sheet of residues 36-43 in chain A (b) of 
the Rubisco-EPYC149-72 density map and structural model. The 
densities are shown as meshwork in gray. The backbones of 
the structural model are in ribbon representation, and side 
chains are shown in stick representation. c-d, Representative 
cryo-EM density quality showing water molecules as orange 
spheres. One water molecule between R312 and E136 on 
chain A is shown in panel c, and another water molecule 
between D137 and K316 on chain A is shown in panel d. e, 
Fourier shell correlation (FSC) curves of the final density maps 
of apo Rubisco and the Rubisco-EPYC1 peptide complexes. Extended Data Fig. 4 Comparison of our EM 
structure of apo Rubisco 
and the published X-ray 
crystallography structure 




comparison of our EM 
structure of apo Rubisco 




a, Comparison of the structure of the small subunit of apo 
Rubisco obtained here by EM with 1gk8. The EM structure has 
additional C-terminus density past residue 126, circled by a 
red dashed line. b, Comparison of our two EM structures of 
the small subunit: from apo Rubisco and from EPYC149-72 
peptide-bound Rubisco. c, Comparison of the structure of the 
large subunit of apo Rubisco obtained here by EM with 1gk8. 
The three major differences found between the X-ray 
structure and the EM structure of the large subunit are circled 
with red dashed lines. d, Comparison of our two EM structures 
of the large subunit: from apo Rubisco and from EPYC149-72 
peptide-bound Rubisco. The major difference found between 
the EPYC149-72 peptide-bound structure and the apo EM 
structure was the loop between K175 and L180 of the large 
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subunit, which is shown circled by a red dashed line. Extended Data Fig. 5 Additional residues may 
contribute to the 
interaction between 
EPYC1 and Rubisco. 
Extended_Data_Fig. 
5-20200804-4.jpg 
Our Rubisco-EPYC149-72 peptide structure suggests that R56 of 
the EPYC149-72 peptide may interact with D31 of the Rubisco 
small subunit and E433 of the Rubisco large subunit (the 
atoms of the backbone of E433 are also shown to display the 
possible interaction). R51 of the EPYC149-72 peptide may form a 
salt bridge with Y32 of the Rubisco small subunit. Residues S57 
and V58 of the EPYC149-72 peptide are close to D31 in the 
structure, which may explain why replacing either of these 
residues with a negatively charged residue disrupts binding 
(Fig. 4a). Extended Data Fig. 6 The EPYC1106-135 peptide 
binds to Rubisco small 
subunit α-helices via salt 
bridges and a 
hydrophobic pocket in a 




a, The EPYC1106-135 peptide represents the second, third and 
fourth Rubisco-binding regions of EPYC1 indicated by pink 
lines and dash line (the peptide is a perfect match to the 
second and fourth Rubisco-binding regions, and there is a one-
amino acid difference between the peptide and the third 
repeat). b-c, Side view (b) and top view (c) of the density map 
of the EPYC1106-135 peptide-Rubisco complex. Dashes in panel b 
indicate regions shown in panels d-i. d-e, Front (d) and side (e) 
views of the EPYC1106-135 peptide (red) bound to the two ⍺-
helices of the Rubisco small subunit (blue). f-g, Three pairs of 
residues form salt bridges between the helix of the EPYC1106-
135 peptide and the helices on the Rubisco small subunit. 
Shown are front (f) and side (g) views as in panel d and panel 
e. The distances from EPYC1 K127, R134 and E129 to Rubisco 
small subunit E24, D23 and R91 are 2.96 Å, 3.17 Å, and 2.68 Å, 
respectively. h-i, A hydrophobic pocket is formed by three 
residues of the EPYC1106-135 peptide and three residues of helix 
B of the Rubisco small subunit. Shown are front (h) and side (i) 
views as in panel d and panel e. j, Summary of the interactions 
observed between the EPYC1106-135 peptide and the two α-
helices of the Rubisco small subunit. Helices are highlighted; 
the residues mediating interactions are bold; salt bridges are 
shown as dotted lines; residues contributing to the 
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hydrophobic pocket are shown in black. k, Color keys used in 
this figure. Extended Data Fig. 7 Surface plasmon 
resonance analysis of 
binding of point mutants 
of EPYC155-72 to Rubisco. 
Extended_Data_Fig. 
7-20200722.jpg 
The wild-type (WT) peptide or peptides with the indicated 
mutations were synthesized, and their Rubisco-binding signal 
was measured by surface plasmon resonance. Extended Data Fig. 8 Interface residues on 
EPYC1 identified by cryo-
EM are important for 
binding and phase 




a, SDS-PAGE analysis of purified proteins used for in vitro 
phase separation experiments. WT = wild-type EPYC1; R/K = 
EPYC1R64A/K127A/K187A/K248A/R314. b-c, A droplet sedimentation 
assay was used as a readout of phase separation 
complementary to the microscopy analyses shown in Fig. 4b. 
Proteins at indicated concentrations were mixed and 
incubated for 10 minutes, then condensates were pelleted by 
centrifugation. Supernatant (S) and pellet (P) fractions were 
run on a denaturing gel. The negative controls with no Rubisco 
or with no EPYC1 are shown in (b), and the wild-type Rubisco 
with wild-type EPYC1 or mutant EPYC1 are shown in (c). Data 
shown here are representative of two independent replicates. Extended Data Fig. 9 Yeast two-hybrid assays 
of interactions between 
EPYC1 and wild-type or 




Colonies are shown after 3 days growth on plates. A subset of 
the data shown in this figure is shown in Fig. 5a. 
Extended Data Fig. 10 Selection of the Rubisco 
small subunit mutant 




a, The Rubisco small subunit-less mutant T60 (Δrbcs) was 
transformed with DNA encoding wild-type and mutant 
Rubisco small subunits (RBCS) to produce candidate 
transformants with the genotypes Δrbcs;RBCSWT, 
Δrbcs;RBCSD23A/E24A, and Δrbcs;RBCSM87D/V94D. Total protein 
extracts for three strains from each transformation were 
separated on a polyacrylamide gel. b, The gel shown in panel a 
was probed by Western blot using a polyclonal antibody 
mixture that detects both large and small Rubisco subunits. 
The experiments shown in panel a and b were performed 
once for selecting the candidate transformants with the 
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highest RBCS expression level from each genotype, in case any 
phenotype may be caused by low expression level of Rubisco. 
Selected strains are indicated by an arrow below the lanes and 
were used for the subsequent phenotypic analyses shown in 
Fig. 5 and panel c. c, Additional representative TEM images of 
whole cells of the strains expressing wild-type, D23A/E24A, 
and M87D/V94D Rubisco small subunit. Scale bar = 500 nm. 
For each strain, at least 25 images (one image for one cell) 
were taken and showing similar results. 
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 Peptide position along EPYC1
18 amino acid peptide
cTP Repeat 1 Repeat 2 Repeat 3 Repeat 4 Repeat 5
Rubisco
EPYC1
27              AARGSWRESSTATVQAS---RASSA---TNR-VSPTRSVLPANWRQELESLRNGNGS 76  Repeat 1
77  SSAASSAPAPARSSSASWRDAAPASSAPA---RSSSA---SKKAVTPSRSALPSNWKQELESLRS--SS 137 Repeat 2
138 PAPASSAPAPARSSSASWRDAAPASSAPA---RSSS----SKKAVTPSRSALPSNWKQELESLRS--SS 197 Repeat 3
198 PAPASSAPAPARSSSASWRDAAPASSAPA---RSSSA---SKKAVTPSRSALPSNWKQELESLRS-N-S 258 Repeat 4
259 PAPASSAPAPARSSSASWRDA-PASSSSSSADKAGTNPWTGKSKPEIKRTALPADWRKGL          317 Repeat 5
                :: .***::: *:   :   :: :     :     .*:.**::*:: *
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